| Ytd | 49.44% | |
| 1y | 44.62% |
| Open | 2.68 | Prev Close | 2.70 | Low | 2.66 | High | 2.71 | Mkt Cap | 216.74M |
| Vol | 1.22M | Avg Vol | 712.12K | EPS | 0.23 | P/E | 11.70 | Forward P/E | 2.79 |
| Beta | 0.67 | Short Ratio | 22.71 | Inst. Own | 5.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 2.46 | 200-d Avg | 2.29 | 1yr Est | 14.00 |
Protalix BioTherapeutics, Inc. (PLX) Presents at Morgan Stanley 24th Annual Global Healthcare Confer
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Protalix BioTherapeutics (AMEX:PLX)
CARMIEL, Israel, Sept. 8, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX),
Protalix BioTherapeutics, Inc. (PLX) Q2 2026 Earnings Call Transcript
Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.05 per share which missed the
Company to host conference call and webcast today at 8:00 a.m. EDT Revenues from selling goods incre
Company to host conference call and webcast at 8:00 a.m. EDT CARMIEL, Israel, Aug. 5, 2026 /PRNewswi
Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market s
Protalix BioTherapeutics, Inc. (PLX) Q1 2026 Earnings Call Transcript
Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.22 per share which beat the an
Company to host conference call and webcast today at 8:00 a.m. EDT Elfabrio commercial execution con
Company to host conference call and webcast at 8:00 a.m. EDT CARMIEL, Israel, May 6, 2026 /PRNewswir
Protalix BioTherapeutics reported weaker FY25 results but issued robust FY26 revenue guidance of $78
American and European households may be growing wealthier at a similar pace, but the composition of
Tesla Inc (NASDAQ:TSLA) CEO Elon Musk on Thursday shared an update on the company’s semiconductor pl
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Protalix BioTherapeutics (AMEX:PLX)
Protalix BioTherapeutics, Inc. (PLX) Q4 2025 Earnings Call Transcript
Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) reported its 2025 financial results and outlined
Financial Outlook: Building Durable Growth and Long–Term ValueProtalix enters 2026 with a profitable
Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.06) per share which missed the
Company to host conference call and webcast today at 8:00 a.m. EDT The European Commission (EC) appr
Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) reported its 2025 financial results and outlined
Shares in Pennon Group PLC (LSE:PNN, OTC:PEGRY) rose 3.4% to 553.5p on Tueaday morning despite the o
AIM modelling company raises £450,000 at a steep discount, betting that investment in growth will ju
Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) announced that the European Commission has appro
Protalix Biotherapeutics Inc (NYSE-A:PLX, FRA:PBDA) announced that the European Commission has appro
The US Justice Department has reportedly reached a settlement with Ticketmaster and its parent compa
European Commission approved dosing regimen reduces the burden for eligible patients, their families
Committee for Medicinal Products for Human Use (CHMP) issues a positive opinion following re-examina
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for it
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
The Dow Jones closed lower by around 300 points on Friday. When insiders purchase or sell shares, it
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss a
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly ear
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings f
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to repor